Inventor · disambiguated record
Edmund A. Rossi
Also filed as: ROSSI EDMUND · ROSSI EDMUND A
77 granted patents·26 pending applications·2,767 citations·filing 2002–2019
99Inventor score
Files withIBC PHARMACEUTICALS INC45IMMUNOMEDICS INC29CHANG CHIEN-HSING17GOLDENBERG DAVID M5ROSSI EDMUND A2
Top patents by PatentIndex Score
103 records- 0199US8349332B2Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseasesIBC PHARMACEUTICALS INC·Filed 2011·Granted Jan 8, 2013·58 cites·12 claims
- 0299US8034352B2Tetrameric cytokines with improved biological activityIBC PHARMACEUTICALS INC·Filed 2010·Granted Oct 11, 2011·61 cites·6 claims
- 0399US7906121B2Methods and compositions for generating bioactive assemblies of increased complexity and usesIBC PHARMACEUTICALS INC·Filed 2009·Granted Mar 15, 2011·125 cites·25 claims
- 0499US7906118B2Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technologyIBC PHARMACEUTICALS INC·Filed 2009·Granted Mar 15, 2011·90 cites·17 claims
- 0599US7666400B2PEGylation by the dock and lock (DNL) techniqueIBC PHARMACEUTICALS INC·Filed 2007·Granted Feb 23, 2010·158 cites·21 claims
- 0699US7550143B2Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and usesIBC PHARMACEUTICALS INC·Filed 2006·Granted Jun 23, 2009·177 cites·21 claims
- 0799US7534866B2Methods and compositions for generating bioactive assemblies of increased complexity and usesIBC PHARMACEUTICALS INC·Filed 2006·Granted May 19, 2009·287 cites·18 claims
- 0899US7527787B2Multivalent immunoglobulin-based bioactive assembliesIBC PHARMACEUTICALS INC·Filed 2006·Granted May 5, 2009·293 cites·23 claims
- 0999US7521056B2Stably tethered structures of defined compositions with multiple functions or binding specificitiesIBC PHARMACEUTICALS INC·Filed 2006·Granted Apr 21, 2009·297 cites·28 claims
- 1098US9382329B2Disease therapy by inducing immune response to Trop-2 expressing cellsIBC PHARMACEUTICALS INC·Filed 2015·Granted Jul 5, 2016·23 cites·15 claims
- 1198US9315567B2T-cell redirecting bispecific antibodies for treatment of diseaseIBC PHARMACEUTICALS INC·Filed 2013·Granted Apr 19, 2016·47 cites·10 claims
- 1298US8597659B2Tetrameric cytokines with improved biological activityCHANG CHIEN-HSING·Filed 2011·Granted Dec 3, 2013·50 cites·12 claims
- 1398US8551480B2Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activityCHANG CHIEN-HSING·Filed 2010·Granted Oct 8, 2013·48 cites·3 claims
- 1498US8475794B2Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseasesCHANG CHIEN-HSING·Filed 2011·Granted Jul 2, 2013·44 cites·7 claims
- 1598US8282934B2Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technologyCHANG CHIEN-HSING·Filed 2011·Granted Oct 9, 2012·49 cites·17 claims
- 1698US8277817B2PEGylation by the dock and lock (DNL) techniqueCHANG CHIEN-HSING·Filed 2011·Granted Oct 2, 2012·44 cites·11 claims
- 1798US8246960B2Methods and compositions for generating bioactive assemblies of increased complexity and usesCHANG CHIEN-HSING·Filed 2011·Granted Aug 21, 2012·55 cites·21 claims
- 1898US8211440B2Multivalent immunoglobulin-based bioactive assembliesCHANG CHIEN-HSING·Filed 2010·Granted Jul 3, 2012·57 cites·25 claims
- 1998US8163291B2Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and usesCHANG CHIEN-HSING·Filed 2009·Granted Apr 24, 2012·52 cites·28 claims
- 2098US8003111B2Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivoIBC PHARMACEUTICALS INC·Filed 2010·Granted Aug 23, 2011·71 cites·10 claims
- 2198US7981398B2PEGylation by the dock and lock (DNL) techniqueIBC PHARMACEUTICALS INC·Filed 2009·Granted Jul 19, 2011·58 cites·25 claims
- 2298US7871622B2Stably tethered structures of defined compositions with multiple functions or binding specificitiesIBC PHARMACEUTICALS INC·Filed 2009·Granted Jan 18, 2011·74 cites·14 claims
- 2398US7858070B2Multivalent immunoglobulin-based bioactive assembliesIBC PHARMACEUTICALS INC·Filed 2009·Granted Dec 28, 2010·71 cites·12 claims
- 2497US9180205B2Stable compositions of high-concentration allotype-selected antibodies for small-volume administrationIMMUNOMEDICS INC·Filed 2014·Granted Nov 10, 2015·52 cites·23 claims
- 2597US8435540B2Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in VIVOCHANG CHIEN-HSING·Filed 2012·Granted May 7, 2013·47 cites·9 claims
- 2697US8333971B2Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragmentsGOLDENBERG DAVID M·Filed 2007·Granted Dec 18, 2012·29 cites·20 claims
- 2797US8158129B2Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivoCHANG CHIEN-HSING·Filed 2011·Granted Apr 17, 2012·49 cites·10 claims
- 2896US9670286B2Disease therapy by inducing immune response to Trop-2 expressing cellsIBC PHARMACEUTICALS INC·Filed 2016·Granted Jun 6, 2017·9 cites·14 claims
- 2996US9475883B2Therapeutic use of anti-CD22 antibodies for inducing trogocytosisIMMUNOMEDICS INC·Filed 2015·Granted Oct 25, 2016·10 cites·13 claims
- 3096US8658773B2Ultrafiltration concentration of allotype selected antibodies for small-volume administrationZENG LI·Filed 2012·Granted Feb 25, 2014·46 cites·18 claims
- 3196US7537930B2Mammalian cell lines for increasing longevity and protein yield from a cell cultureIMMUNOMEDICS INC·Filed 2006·Granted May 26, 2009·30 cites·12 claims
- 3295US10111954B2Combination therapy for inducing immune response to diseaseIBC PHARMACEUTICALS INC·Filed 2016·Granted Oct 30, 2018·8 cites·13 claims
- 3395US9682143B2Combination therapy for inducing immune response to diseaseIBC PHARMACEUTICALS INC·Filed 2013·Granted Jun 20, 2017·18 cites·13 claims
- 3495US8865176B2Methods and compositions for generating bioactive assemblies of increased complexity and usesCHANG CHIEN-HSING·Filed 2012·Granted Oct 21, 2014·9 cites·4 claims
- 3595US7785880B2Mammalian cell lines for increasing longevity and protein yield from cell cultureIMMUNOMEDICS INC·Filed 2009·Granted Aug 31, 2010·21 cites·7 claims
- 3694US9663576B2Therapeutic use of anti-CD22 antibodies for inducing trogocytosisIMMUNOMEDICS INC·Filed 2016·Granted May 30, 2017·7 cites·7 claims
- 3794US7531327B2Methods and compositions for increasing longevity and protein yield from a cell cultureIMMUNOMEDICS INC·Filed 2005·Granted May 12, 2009·30 cites·17 claims
- 3893US10662252B2Disease therapy by inducing immune response to Trop-2 expressing cellsIBC PHARMACEUTICALS INC·Filed 2017·Granted May 26, 2020·5 cites·7 claims
- 3992US10131712B2Combination therapy with T-cell redirecting bispecific antibodies and checkpoint inhibitorsIBC PHARMACEUTICALS INC·Filed 2017·Granted Nov 20, 2018·5 cites·22 claims
- 4092US9683050B2Stable compositions of high-concentration allotype-selected antibodies for small-volume administrationIMMUNOMEDICS INC·Filed 2015·Granted Jun 20, 2017·9 cites·23 claims
- 4192US8871216B2Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseasesIBC PHARMACEUTICALS INC·Filed 2012·Granted Oct 28, 2014·9 cites·17 claims
- 4291US10245321B2Combination therapy for inducing immune response to diseaseIBC PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·3 cites·8 claims
- 4391US9931413B2Tetrameric cytokines with improved biological activityIBC PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·6 cites·6 claims
- 4491US9879088B2Disease therapy by inducing immune response to Trop-2 expressing cellsIBC PHARMACEUTICALS INC·Filed 2017·Granted Jan 30, 2018·4 cites·8 claims
- 4591US9192664B2Therapeutic use of anti-CD22 antibodies for inducing trogocytosisIMMUNOMEDICS INC·Filed 2012·Granted Nov 24, 2015·7 cites·7 claims
- 4691US8153433B1Mammalian cell lines for increasing longevity and protein yield from a cell cultureGOLDENBERG DAVID M·Filed 2011·Granted Apr 10, 2012·6 cites·15 claims
- 4791US7544487B2Fusion proteins containing recombinant cytotoxic RNAsesIMMUNOMEDICS INC·Filed 2005·Granted Jun 9, 2009·15 cites·8 claims
- 4890US9468689B2Ultrafiltration concentration of allotype selected antibodies for small-volume administrationIMMUNOMEDICS INC·Filed 2013·Granted Oct 18, 2016·10 cites·30 claims
- 4990US8076140B2Mammalian cell lines for increasing longevity and protein yield from a cell cultureGOLDENBERG DAVID M·Filed 2010·Granted Dec 13, 2011·6 cites·14 claims
- 5088US8372603B2Mammalian cell lines for increasing longevity and protein yield from a cell cultureIMMUNOMEDICS INC·Filed 2012·Granted Feb 12, 2013·4 cites·13 claims
Showing the top 50 of 103 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Edmund A. Rossi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →